Ganoderic acid A (GAA) prevents ox-LDL-induced macrophage inflammation and lipid deposition in THP-1 cells by blocking Notch1/PPARγ/CD36 signaling, which may provide a theoretical framework for the clinical application of GAA in the treatment of atherosclerosis (96). This evidence concerns the gene PPARG and atherosclerosis.